PuSH - Publikationsserver des Helmholtz Zentrums München

Zeitschriften-Browsing

78 Datensätze gefunden.
Zum Exportieren der Ergebnisse bitte einloggen.
Alle Publikationen dieser Seite in den Korb legen
41.
El Shafie, R.A.* et al.: Evaluation of particle radiotherapy for the re-irradiation of recurrent intracranial meningioma. Radiat. Oncol. 13:86 (2018)
42.
Grote, M.* ; Maihöfer, C. ; Weigl, M.* ; Davies-Knorr, P.* & Belka, C.: Progressive resistance training in cachectic head and neck cancer patients undergoing radiotherapy: A randomized controlled pilot feasibility trial. Radiat. Oncol. 13:215 (2018)
43.
Ilicic, K. ; Combs, S.E. & Schmid, T.E.: New insights in the relative radiobiological effectiveness of proton irradiation. Radiat. Oncol. 13:6 (2018)
44.
Krauze, A.V.* et al.: Correction to expert consensus on re-irradiation for recurrent glioma. Radiat. Oncol. 13:8 (2018)
45.
Maihoefer, C. et al.: Postoperative (chemo) radiation in patients with squamous cell cancers of the head and neck - clinical results from the cohort of the clinical cooperation group "Personalized Radiotherapy in Head and Neck Cancer". Radiat. Oncol. 13:123 (2018)
46.
Münch, S.* et al.: Comparison of definite chemoradiation therapy with carboplatin/paclitaxel or cisplatin/5-fluoruracil in patients with squamous cell carcinoma of the esophagus. Radiat. Oncol. 13:182 (2018)
47.
Schiller, K.* et al.: Impact of68Ga-PSMA-PET imaging on target volume definition and guidelines in radiation oncology - a patterns of failure analysis in patients with primary diagnosis of prostate cancer. Radiat. Oncol. 13:36 (2018)
48.
Stade, F.* et al.: Influence of68Ga-DOTATOC on sparing of normal tissue for radiation therapy of skull base meningioma: Differential impact of photon and proton radiotherapy. Radiat. Oncol. 13:58 (2018)
49.
Straube, C.* et al.: Dosimetric impact of tumor treating field (TTField) transducer arrays onto treatment plans for glioblastomas - a planning study. Radiat. Oncol. 13:31 (2018)
50.
Zschaeck, S.* et al.: PSMA-PET based radiotherapy: A review of initial experiences, survey on current practice and future perspectives. Radiat. Oncol. 13:90 (2018)
51.
Dittmar, J.O.* et al.: First intraindividual comparison of contrast-enhanced MRI, FET- and DOTATOC- PET in patients with intracranial meningiomas. Radiat. Oncol. 12:169 (2017)
52.
Dreher, C.* ; Habermehl, D. ; Jäkel, O.* & Combs, S.E.: Effective radiotherapeutic treatment intensification in patients with pancreatic cancer: Higher doses alone, higher RBE or both? Radiat. Oncol. 12:203 (2017)
53.
Duma, M.N. et al.: Helical TomoTherapy for locally advanced or recurrent breast cancer. Radiat. Oncol. 12:31 (2017)
54.
Hegemann, N.S.* et al.: Risk of second cancer following radiotherapy for prostate cancer: A population-based analysis. Radiat. Oncol. 12:2 (2017)
55.
Krauze, A.* et al.: Expert consensus on re-irradiation for recurrent glioma. Radiat. Oncol. 12:194 (2017)
56.
Münch, S.* et al.: Comparison of neoadjuvant chemoradiation with carboplatin/ paclitaxel or cisplatin/ 5-fluoruracil in patients with squamous cell carcinoma of the esophagus. Radiat. Oncol. 12:182 (2017)
57.
Münch, S.* ; Oechsner, M.* ; Combs, S.E. & Habermehl, D.: DVH- and NTCP-based dosimetric comparison of different longitudinal margins for VMAT-IMRT of esophageal cancer. Radiat. Oncol. 12:128 (2017)
58.
Pigorsch, S.U. et al.: Do selective radiation dose escalation and tumour hypoxia status impact the loco-regional tumour control after radio-chemotherapy of head & neck tumours? The ESCALOX protocol. Radiat. Oncol. 12:45 (2017)
59.
Straube, C.* et al.: Does age really matter? Radiotherapy in elderly patients with glioblastoma, the Munich experience. Radiat. Oncol. 12:77 (2017)
60.
Michna, A. et al.: Transcriptomic analyses of the radiation response in head and neck squamous cell carcinoma subclones with different radiation sensitivity: Time-course gene expression profiles and gene association networks. Radiat. Oncol. 11:94 (2016)